ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,427.13
      -2.31%
      US Tech 100
      18,600.00
      -3.25%
      Dow Jones
      39,853.87
      -1.25%
      Brent Oil
      80.30
      -0.54%
      Bitcoin
      64,250.17
      -1.72%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Enanta Pharmaceuticals Inc (ENTA)

      7. Enanta Pharmaceuticals Inc (ENTA) Financials

      Enanta Pharmaceuticals Inc

      Enanta Pharmaceuticals Inc (ENTA)

      NASDAQ
      15.02
      0.03
      (0.20%)
      Closed July 25 4:00PM
      Delayed by 15 minutes
      15.05
      0.03
      (0.20%)
      After Hours: 6:45PM
      Delayed by 15 minutes

      Enanta Pharmaceuticals Inc Financial Summary

      The current ENTA market cap is 318.75M. The company's latest EPS is USD -6.3182 and P/E is -2.37.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 17.8M18.89M18.93M18M17.05M
      Operating Income -39.45M-36.71M-31.03M-34.89M-32.77M
      Net Income -37.66M-39.07M-28.11M-33.41M-31.16M
      Year End September 29 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 205.2M122.47M97.07M86.16M79.2M
      Operating Income 36.74M-41.64M-109.57M-123.84M-137.21M
      Net Income 46.38M-36.17M-79M-121.76M-133.82M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 326.45M495.17M462.28M428.5M413.56M
      Total Liabilities 57.07M257.35M245.54M236.62M247.44M
      Total Equity 269.38M237.82M216.74M191.88M166.11M
      Year End September 29 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 489.83M486.13M438.79M375.41M462.28M
      Total Liabilities 27.34M30.55M39.36M54.08M245.54M
      Total Equity 462.49M455.58M399.43M321.33M216.74M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -49.42M-81.55M-103.15M-24.99M-53.59M
      Investing 80.33M-65.41M-53.58M-13.12M45.51M
      Financing -1.73M198.15M198.13M-7.35M-13.76M
      Year End September 29 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 71.42M7.09M-70M-84.78M-103.15M
      Investing -86.66M19.83M36.99M54.9M-53.58M
      Financing 2.57M8.98M3.08M20.03M198.13M

      Stats and Ratios

      Market Cap 318.75M
      Price to Earnings Ratio -2.37
      Price to Sales Ratio 4.01
      Price to Cash Ratio 3.72
      Price to Book Ratio 1.46
      Dividend Yield -

      Share Statistics

      Shares Outstanding 21.18M
      Average Volume (1 week) 159.68k
      Average Volume (1 Month) 214.48k
      52 Week Change -20.12%
      52 Week High 20.04
      52 Week Low 8.08
      Spread (Intraday) 6.82 (40.55%)

      Company Info

      Company Name Enanta Pharmaceuticals Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.enanta.com
      Industry pharmaceutical preparations (2834)